Company intelligence / Profile preview

PeriGen

Cary, North Carolina, United Statesperigen.com ↗

Ownership: Private
Development stage: Other

Overview

Clinical studies and real-world use have shown that the company's AI-powered perinatal monitoring solutions are associated with reduced complications such as uterine tachysystole and NICU admissions. Their technology has demonstrated significant decreases in cesarean and operative vaginal delivery rates in exposed populations while supporting improved labor assessment and patient safety

Therapeutic areas: Women's Health
Modalities: Device (perinatal monitoring software)Non-pharmacological therapy (clinical decision support)
Industry: Digital Health Medical Devices

Partnerships

GE Healthcare licensed the company's technology to enhance its Centricity* perinatal suite.

Beyond the preview

Go deeper on PeriGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PeriGen.

Explore the full profile